Cat.#: ACPP-1846
| Despition | FGF 9 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% by RP-HPLC and SDS-PAGE. |
| Form | Sterile Filtered white lyophilized powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1754 | Human VEGFC Protein, Sf9 (AC1754) | 2 µg | inquiry |
| ACPP-1280 | SRPX2 Blocking Peptide (AC1280) | 250 µg | inquiry |
| ACPP-1533 | Human NREP Protein (AC1533) | 2 µg | inquiry |
| ACPP-1118 | Human Insulin (Active) (AC1118) | 25 mg | inquiry |
| ACPP-1671 | Human SPINT2 Protein, Sf9 (AC1671) | 2 µg | inquiry |
| ACPP-1401 | Rat Midkine Protein (AC1401) | 5 µg | inquiry |
| ACPP-1384 | Human RPL5 Protein (AC1384) | 2 µg | inquiry |
| ACPP-1091 | BMP11 Blocking Peptide (AC1091) | 250 µg | inquiry |
| ACPP-1734 | Human EFNA3 Protein (AC1734) | 5 µg | inquiry |
| ACPP-1136 | TYRO3 Blocking Peptide (AC1136) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.